Conoscere EBM
- Definizione
- Acronimi
- Cronologia
- Ambiti
- Know-how e strumenti
- EBM in 4 step
- Limiti e ostacoli

EB Practice
- Formulazione quesito
- Ricerca evidenze
- Valutazione evidenze
- Applicazione evidenze

EBHC Library
- Risorse in italiano

SSN Hot Topics
- Appropriatezza
- Conflitti di interesse
- ECM
- Farmaci
- Governo Clinico
- LEA

InfoSanità

Archivio > News 2005

Page last update: 08/01/2008

• Piano Nazionale Linee Guida
  • Il coinvolgimento dei cittadini nelle scelte in Sanità

• N Engl J Med, 29 dicembre
  • Trial Registration at ClinicalTrials.gov between May and October 2005
  • Registries and Registration of Clinical Trials

• BMJ, 24 dicembre
  • How Google is changing medicine
  • White coats and fingerprints: diagnostic reasoning in medicine and investigative methods of fictional detectives

• Ann Intern Med, 20 dicembre
  • Effect of Increasing the Intensity of Implementing Pneumonia Guidelines: A Randomized, Controlled Trial

• Bandolier 136

• BMJ, 17 dicembre
  • The NHS revolution: health care in the market place: Medical generalists: connecting the map and the territory

• Arch Intern Med, 12/26 dicembre
  • Peer Review and Professionalism at the Archives of Internal Medicine

• Conference report. 3rd International Conference of Evidence-Based Health Care Teachers & Developers

• BMJ, 10 dicembre
  • Extra scrutiny for industry funded trials
  • Payment to healthcare professionals for patient recruitment to trials: a systematic review
  • Learning in practice. Developing guidelines for medical students about the examination of patients under 18 years old
  • ABC of health informatics: eHealth and the future: promise or peril?
  • Rise and demise of the hospital: a reappraisal of nursing
  • The NHS revolution: health care in the market place: Practice based commissioning: applying the research evidence
  • Primary care in the United States: problems and possibilities
  • Designing research in vulnerable populations: lessons from HIV prevention trials that stopped early

• MJA, 5/19 dicembre
  • Can medical journals lead or must they follow?

• Conference report. 3rd International Conference of Evidence-Based Health Care Teachers & Developers

• Lancet, 3 dicembre
  • Nature's randomised trials

• BMJ, 3 dicembre
  • Are experimental treatments for cancer in children superior to established treatments? Observational study of randomised controlled trials by the Children's Oncology Group
  • ABC of health informatics: Communication and navigation around the healthcare system
  • The NHS revolution: health care in the market place: Should the NHS follow the American way?
  • Does the district general hospital have a future?

• N Engl J Med, 1 dicembre
  • Observational Studies of Drugs and Mortality

• Arch Intern Med, 28 novembre
  • Quality of Care and Outcomes of Older Patients With Heart Failure Hospitalized in the United States and Canada
  • Ties That Bind: Multiple Relationships Between Clinical Researchers and the Pharmaceutical Industry

• Lancet, 26 novembre
  • The UK drug industry: responsible, ethical, and professional?

• JAMA, 23 novembre
  • Quality, Innovation, and Value for Money: NICE and the British National Health Service
  • Drug Prices and Value for Money: The Australian Pharmaceutical Benefits Scheme

• CMAJ, 22 novembre
  • Clinical practice guidelines and conflict of interest
  • Preventive care: so many recommendations, so little time

• MJA, 21 novembre
  • Surgical accountability: a framework for trust and change
  • The Western Australian Audit of Surgical Mortality: advancing surgical accountability
  • Health care safety: what needs to be done?

• Bandolier, 135

• Lancet, 19 novembre
  • Public-private partnerships for neglected diseases
  • Cochrane Collaboration and the evolution of evidence

• BMJ, 19 novembre
  • ABC of health informatics: Improving services with informatics tools
  • The NHS revolution: health care in the market place
    • Challenges of private provision in the NHS
    • Competition in general practice
    • What do patients and the public want from primary care?

• JAMA, 16 novembre
  • Why America Needs a Strong FDA

• BMJ, 12 novembre
  • Improvements in quality of clinical care in English general practice 1998-2003: longitudinal observational study
  • ABC of health informatics: Keeping up: learning in the workplace
  • The NHS revolution: health care in the market place
    • Use of private health care in the NHS

• N Engl J Med, 10 novembre
  • Recertification for Internists — One "Grandfather's" Experience

• JAMA, 9 novembre
  • Clinical Decision Support and Appropriateness of Antimicrobial Prescribing: A Randomized Trial
  • Appropriate Use of Antimicrobial Drugs: A Better Prescription Is Needed

• MJA, 7 novembre
  • Teaching on the run tips 11: the junior doctor in difficulty

• BMJ, 5 novembre
  • Including older people in clinical research
  • Effectiveness and efficiency of search methods in systematic reviews of complex evidence: audit of primary sources
  • ABC of health informatics: Referral or follow-up?
  • Medical paternalism and expensive unsubsidised drugs

• JAMA, 2 novembre
  • Randomized Trials Stopped Early for Benefit: A Systematic Review
  • When (Not) to Stop a Clinical Trial for Benefit

• Lancet, 22 ottobre
  • Reorienting health-research communication

• BMJ, 22 ottobre
  • Appropriateness of use of medicines in elderly inpatients: qualitative study
  • Recruiting patients to medical research: double blind randomised trial of "opt-in" versus "opt-out" strategies
  • Bias from requiring explicit consent from all participants in observational research: prospective, population based study
  • Effect of diverging policy across the NHS
  • ABC of health informatics: How informatics tools help deal with patients' problems
  • Foreign free riders and the high price of US medicines

• N Engl J Med, 13 ottobre
  • Translational and Clinical Science — Time for a New Vision

• Va Pensiero, 19 ottobre
  • Ancora un'intervista evidence-based.... Ritratto di Nino Cartabellotta

• JAMA, 19 ottobre
  • The Rational Clinical Examination.Does This Dyspneic Patient in the Emergency Department Have Congestive Heart Failure?

• Ann Intern Med, 18 ottobre
  • Exorcising Ghosts and Unwelcome Guests

• BMJ, 15 ottobre
  • ABC of health informatics: How computers can help to share understanding with patients
  • Disappointing biotech
  • Simultaneous comparison of multiple treatments: combining direct and indirect evidence
  • Towards evidence based bioethics
  • Statistics Notes: Standard deviations and standard errors

• N Engl J Med, 13 ottobre
  • Translational and Clinical Science — Time for a New Vision

• JAMA, 12 ottobre
  • Early Experience With Pay-for-Performance: From Concept to Practice
  • Pay-for-Performance Research: How to Learn What Clinicians and Policy Makers Need to Know

• CMAJ, 11 ottobre
  • Improving patient safety: moving beyond the "hype" of medical errors

• BMJ, 8 ottobre
  • "Breakthrough" drugs and growth in expenditure on prescription drugs in Canada
  • ABC of health informatics: How decision support tools help define clinical problems
  • Medicines regulation and the pharmaceutical industry
  • At the frontier of biomedical publication: Chicago 2005

• N Engl J Med, 6 ottobre
  • Medicare and Cost-Effectiveness Analysis

• MJA, 4 ottobre
  • Modernising the National Health and Medical Research Council
  • Electronic medical handover: towards safer medical care

• Lancet, 1 ottobre
  • What is going on at the FDA?
  • Personal digital assistants in health care: experienced clinicians in the palm of your hand?

• Lancet, 15 settembre
  • Developing an open relationship with the drug industry

• BMJ, 25 settembre
  • Series, PowerPoint slides, and folders now available on bmj.com

• JAMA, 21 settembre.
  • Theme Issue: Medical Research-State of the Science

• BMJ 17 settembre
  • Evidence based reform of mental health care
  • Reforming research ethics committees
  • ABC of health informatics: Is a consultation needed?
  • Developing clinical guidelines: a challenge to current methods

• Arch Intern Med, 12 settembre
  • Disclosing Harmful Medical Errors to Patients: A Time for Professional Action

• BMJ, 10 settembre
  • Regulating the drugs industry transparently
  • Learning in practice.Intellectual aptitude tests and A levels for selecting UK school leaver entrants for medical school
  • ABC of health informatics: What is health information?
  • Open label extension studies: research or marketing?

• JAMA, 7 settembre. Theme issue: Medical education

• MJA, 5 settembre
  • Problem-based learning: a dissemination success story?
  • Evidence in palliative care research: how should it be gathered?
  • Teaching on the run tips 10: giving feedback

• Bandolier, 134

• Lancet, 3 settembre
  • The changing face of NICE: the same but different

• BMJ, 3 settembre
  • Analysis of quality of interventions in systematic reviews

• PloS, agosto 2005
  • Why Most Published Research Findings Are False

• CMAJ, 30 agosto
  • Frequency, type and clinical importance of medication history errors at admission to hospital: a systematic review

• Lancet, 27 agosto
  • The end of homoeopathy
  • Homoeopathy and “the growth of truth”
  • Are the clinical effects of homoeopathy placebo effects? Comparative study of placebo-controlled trials of homoeopathy and allopathy

• BMJ, 20 agosto
  • Systematic review of publication bias in studies on publication bias
  • Evidence based case report: Should a patient with primary intracerebral haemorrhage receive antiplatelet or anticoagulant therapy?
  • Need for differential discounting of costs and health effects in cost effectiveness analyses

• Lancet, 20 agosto
  • Technology can make patients safer
  • Buying results? Contracting for health service delivery in developing countries

• CMAJ, 16 agosto
  • Tips for learners of evidence-based medicine: 5. The effect of spectrum of disease on the performance of diagnostic tests

• Ann Intern Med, 16 agosto
  • Promoting Informed Choice: Transforming Health Care To Dispense Knowledge for Decision Making
  • Modeling Complex Medical Decision Problems with the Archimedes Model

• MJA, 15 agosto
  • Australia’s media reporting of health and medical matters: a question of quality
  • Monitoring the quality of medical news reporting: early experience with media doctor
  • New website is no miracle cure
  • Evidence-based journalism: a forlorn hope?
  • Medical news reporting: establishing goodwill and cooperation
  • Attitudes of oncology health professionals to information from the Internet and other media

• JAMA, 10 agosto
  • Clinical Practice Guidelines and Quality of Care for Older Patients With Multiple Comorbid Diseases: Implications for Pay for Performance
  • Disclosing Individual Results of Clinical Research: Implications of Respect for Participants
  • Adding Value to Evidence-Based Clinical Guidelines

• BMJ, 6 agosto
  • The patient safety story

• N Engl J Med, 4 agosto
  • Drug Therapy: Adherence to Medication

• Ann Intern Med, 2 agosto
  • The Costs of a National Health Information Network
  • A Randomized Trial of Ways To Describe Test Accuracy: The Effect on Physicians' Post-Test Probability Estimates
  • Electronic Health Records: Just around the Corner? Or over the Cliff?
  • Electronic Health Records and the National Health Information Network: Affordable, Adoptable, and Ready for Prime Time?

• Lancet, 29 luglio
  • Will consumerism lead to better health?
  • Should journals publish industry-funded bioethics articles?

• BMJ, 29 luglio
  • Investigating allegations of scientific misconduct
  • Evidence based prescribing
  • Systematic comparison of four sources of drug information regarding adjustment of dose for renal function
  • Are these data real? Statistical methods for the detection of data fabrication in clinical trials
  • Suspected research fraud: difficulties of getting at the truth
  • Investigating the previous studies of a fraudulent author

• JAMA, 27 luglio
  • Efficiency in the Health Care Industries: A View From the Outside

• BMJ, 22 luglio
  • Supply and regulation of medicines
  • Comparison of amount of biomedical research originating from the European Union and the United States
  • Commentary: Bridging the gaps in biomedical research

• Lancet, 22 luglio
  • Undue inducement in clinical research
  • Undue inducement in clinical research in developing countries: is it a worry?

• N Engl J Med, 21 luglio
  • Quality of Care in U.S. Hospitals as Reflected by Standardized Measures, 2002–2004
  • Care in U.S. Hospitals — The Hospital Quality Alliance Program
  • Improving the Quality of Hospital Care in America

• JAMA, 20 luglio
  • Optimizing the Science of Quality Improvement

• MJA, 18 luglio
  • Doctors, drugs, information and ethics: a never-ending story
  • Pharmaceutical advertisements in prescribing software: an analysis

• BMJ, 22 luglio
  • Supply and regulation of medicines
  • Comparison of amount of biomedical research originating from the European Union and the United States
  • Commentary: Bridging the gaps in biomedical research

• Lancet, 22 luglio
  • Undue inducement in clinical research
  • Undue inducement in clinical research in developing countries: is it a worry?

• N Engl J Med, 21 luglio
  • Quality of Care in U.S. Hospitals as Reflected by Standardized Measures, 2002–2004
  • Care in U.S. Hospitals — The Hospital Quality Alliance Program
  • Improving the Quality of Hospital Care in America

• JAMA, 20 luglio
  • Optimizing the Science of Quality Improvement

• MJA, 18 luglio
  • Doctors, drugs, information and ethics: a never-ending story
  • Pharmaceutical advertisements in prescribing software: an analysis

• N Engl J Med, 14 luglio
  • Financial Conflicts of Interest and the Food and Drug Administration's Advisory Committees

• JAMA, 13 luglio
  • Contradicted and Initially Stronger Effects in Highly Cited Clinical Research

• Arch Intern Med, 11 luglio
  • Quality: The Need for Intelligent Efforts
  • Diagnostic Error in Internal Medicine

• Lancet, 9 luglio
  • Putting clinical trials into context
  • The Good Clinical Practice guideline: a bronze standard for clinical research

• BMJ, 9 luglio
  • Learning in practice.Impact on patients of expanded, general practice based, student teaching: observational and qualitative study
  • Five futures for academic medicine: the ICRAM scenarios

• JAMA, 6 luglio
  • Reporting Conflicts of Interest, Financial Aspects of Research, and Role of Sponsors in Funded Studies

• Ann Intern Med, 5 luglio
  • High and Rising Health Care Costs. Part 4: Can Costs Be Controlled While Preserving Quality?
  • Health Care Expenditures Reexamined

• MJA, 4 luglio
  • The Australian Clinical Trial Registry
  • Teaching on the run tips 9: in-training assessment

• Bandolier, 133

• Lancet, 2 luglio
  • Literature searches: look before you leap

• BMJ, 2 luglio
  • Drug safety and regulation
  • Fate of biomedical research protocols and publication bias in France: retrospective cohort study
  • Global consumption and the challenge to pharmaceutical governance in the United Kingdom

• Arch Intern Med, 27 giugno
  • The Annual Physical: Are Physicians and Patients Telling Us Something?
  • Support of Evidence-Based Guidelines for the Annual Physical Examination: A Survey of Primary Care Providers
  • Adverse Drug Event Surveillance and Drug Withdrawals in the United States, 1969-2002: The Importance of Reporting Suspected Reactions

• BMV - Biblioteca Medica Virtuale (della Provincia di Bolzano)

• BMJ, 25 giugno
  • Where next with revalidation?
  • Health research policy in the European Union
  • Creative use of existing clinical and health outcomes data to assess NHS performance in England: Part 2—more challenging aspects of monitoring
  • Programme budgeting and marginal analysis: bridging the divide between doctors and managers
  • GMC and the future of revalidation: Time for radical reform

• N Engl J Med, 23 giugno
  • The Lessons of Vioxx — Drug Safety and Sales

• Ann Intern Med, 21 giugno
  • Supplement. Challenges of Summarizing Better Information for Better Health: The Evidence-based Practice Center Experience
  • Independent Medical Examinations: An Expanding Source of Physician Liability
  • High and Rising Health Care Costs. Part 3: The Role of Health Care Providers
  • Reviews: Making Sense of an Often Tangled Skein of Evidence

• CMAJ, 21 giugno
  • Why should clinical trials be registered?
  • Is this clinical trial fully registered? A statement from the International Committee of Medical Journal Editors

• BMJ, 18 giugno
  • Creative use of existing clinical and health outcomes data to assess NHS performance in England: Part 1—performance indicators closely linked to clinical care
  • GMC and the future of revalidation: Obstacles to maintaining licensure in the United States

• BMJ, 11 giugno
  • Hospital waiting lists and pressures on the NHS
  • Prognosis without treatment as a modifier in health economic assessments
  • GMC and the future of revalidation: Self regulation must be made to work

• Lancet, 11 giugno
  • Patient choice in clinical trials
  • Do n-of-1 trials really tailor treatment?

• N Engl J Med, 9 giugno
  • Is This Clinical Trial Fully Registered? — A Statement from the International Committee of Medical Journal Editors

• Ann Intern Med, 7 giugno
  • High and Rising Health Care Costs. Part 2: Technologic Innovation

• Med J Aust, 6 giugno
  • Research integrity and pharmaceutical industry sponsorship
  • Medical specialists and pharmaceutical industry-sponsored research: a survey of the Australian experience
  • Teaching on the run tips 8: assessment and appraisal

• Bandolier 132

• BMJ, 4 giugno
  • Quality improvement report.Improving the quality of palliative care for ambulatory patients with lung cancer
  • GMC and the future of revalidation: A way forward

• JAMA, 1 giugno
  • Physicians and the Investment Industry

• Lancet, 28 maggio
  • The societal value of health research
  • Is this clinical trial fully registered? A statement from the International Committee of Medical Journal Editors
  • WHO facilitates international collaboration in setting standards for clinical trial registration

• BMJ, 28 maggio
  • Next steps in trial registration
  • Learning in practice.Use of SPRAT for peer review of paediatricians in training
  • Commentary: Can poorly performing doctors blame their assessment tools?
  • No cure, no pay
  • GMC and the future of revalidation: Patients, professionalism, and revalidation

• N Engl J Med, 26 maggio
  • Gag Clauses in Clinical-Trial Agreements
  • Academic Medical Centers' Standards for Clinical-Trial Agreements with Industry

• Arch Intern Med, 26 maggio
  • Decisions on Drug Therapies by Numbers Needed to Treat: A Randomized Trial

• BMJ, 21 maggio
  • Clever searching for evidence
  • Participants in research
  • Systematic review to determine whether participation in a trial influences outcome
  • Optimal search strategies for retrieving scientifically strong studies of treatment from Medline: analytical survey
  • Characteristic and incidental (placebo) effects in complex interventions such as acupuncture
  • GMC and the future of revalidation: Building on the GMC's achievements

• Lancet, 21 maggio
  • Integrating economic analysis into clinical trials

• JAMA, 18 maggio
  • Relative Citation Impact of Various Study Designs in the Health Sciences
  • Five Years After To Err Is Human: What Have We Learned?
  • The Rational Clinical Examination.Is This Patient Having a Stroke?

• Ann Intern Med, 17 maggio
  • Understanding Rising Health Care Costs: Introducing a Series of Articles
  • High and Rising Health Care Costs. Part 1: Seeking an Explanation

• Lancet, 14 maggio
  • No place for conflict of interest

• BMJ, 14 maggio
  • Open access, impact, and demand
  • Open access and openly accessible: a study of scientific publications shared via the internet

• CMAJ, 10 maggio
  • A national strategy for waiting-times research?
  • Canadian prescription drug costs surpass $18 billion

• Arch Intern Med, 9 maggio
  • Are Cyclooxygenase-2 Inhibitors Being Taken Only by Those Who Need Them?

• Lancet, 7 maggio
  • Epidemiology 5. Multiplicity in randomised trials II subgroup and interim analyses

• BMJ, 7 maggio
  • Comparison of descriptions of allocation concealment in trial protocols and the published reports: cohort study
  • Assessment of methodological quality of primary studies by systematic reviews: results of the metaquality cross sectional study
  • Endorsement of the CONSORT statement by high impact medical journals: survey of instructions for authors
  • Adequacy and reporting of allocation concealment: review of recent trials published in four general medical journals
  • Learning in practice.Detecting cheating in written medical examinations by statistical analysis of similarity of answers: pilot study
  • What can mendelian randomisation tell us about modifiable behavioural and environmental exposures?
  • Why clinicians are natural bayesians

• JAMA, 4 maggio
  • The Research on Adverse Drug Events and Reports (RADAR) Project

• Ann Intern Med, 3 maggio
  • Five System Barriers to Achieving Ultrasafe Health Care

• MJA, 2 maggio
  • Improving the governance of health research

• Lancet, 30 aprile
  • Epidemiology 4. Multiplicity in randomised trials I: endpoints and treatments

• BMJ, 30 aprile
  • Surveying the literature from animal experiments
  • Readers guide to critical appraisal of cohort studies: 3. Analytical strategies to reduce confounding

• N Engl J Med, 28 aprile
  • Public Access to NIH-Funded Research

• Bandolier, 131

• BMJ, 23 aprile
  • New arrangements for the Medicines and Healthcare products Regulatory Agency
  • Current controversies: Who needs health care—the well or the sick?
  • Principles for international registration of protocol information and results from human trials of health related interventions: Ottawa statement (part 1)
  • Commentary: Why industry should register and disclose results of clinical studies—perspective of a recovering academic
  • Reader's guide to critical appraisal of cohort studies: 2. Assessing potential for confounding

• Lancet, 23 aprile
  • When clinical practice guidelines fail
  • Epidemiology 3: Refining clinical diagnosis with likelihood ratios

• Ann Intern Med, 19 aprile
  • Ambiguity and Workarounds as Contributors to Medical Error

• MJA, 18 aprile
  • Physical examination: bewitched, bothered and bewildered

• BMJ, 16 aprile
  • The influence of big pharma
  • Reader's guide to critical appraisal of cohort studies: 1. Role and design

• JAMA, 15 aprile
  • The Rational Clinical Examination. Does This Patient Have Myasthenia Gravis?

• Lancet, 22 aprile
  • Epidemiology 2: Compared to what? Finding controls for case-control studies

• BMJ, 9 aprile
  • Quality improvement report. Prophylaxis and follow-up after possible exposure to HIV, hepatitis B virus, and hepatitis C virus outside hospital: evaluation of policy 2000-3
  • Statistics Notes: Treatment allocation by minimisation

• Lancet, 9 aprile
  • Epidemiology 1: Sample size calculations in randomised trials: mandatory and mystical

• Ann Intern Med, 5 aprile
  • Ethics Manual: Fifth Edition

• BMJ, 1 aprile
  • What makes a good clinical decision support system
  • Identifying outcome reporting bias in randomised trials on PubMed: review of publications and survey of authors
  • Perceptions of open access publishing: interviews with journal authors
  • Open access publishing: too much oxygen?
  • Improving clinical practice using clinical decision support systems: a systematic review of trials to identify features critical to success
  • Five pitfalls in decisions about diagnosis and prescribing

• N Engl J Med, 31 marzo
  • Raising the Safety Bar — The FDA's Coxib Meeting
  • Learning the Value of Drugs — Is Rofecoxib a Regulatory Success Story?
  • Standards of Ethics at the National Institutes of Health

• Arch Intern Med, 28 marzo
  • The Effect of Physician Disclosure of Financial Incentives on Trust
  • Physician Strategies to Reduce Patients’ Out-of-pocket Prescription Costs
  • Physicians’ Responses to Resource Constraints

• BMJ, 26 marzo
  • Learning in practice. A new selection system to recruit general practice registrars: preliminary findings from a validation study
  • Commentary: Reassuring evidence on competency based selection
  • Evidence based diagnostics

• Lancet 26 marzo
  • Clinical research is essential to help achieve Europe's goals
  • Peer review: an important and undervalued academic task
  • Epidemiology and reporting of randomised trials published in PubMed journals

• N Engl J Med, 24 marzo
  • Safety in Numbers — Monitoring Risk in Approved Drugs

• MJA 21 marzo
  • The safety of Australian healthcare: 10 years after QAHCS
  • COX-2 inhibitors: exemplars of the drug-safety conundrum
  • Managing adverse drug reactions: time to get serious

• BMJ, 19 marzo
  • Learning in practice.What should undergraduate medical students know about psoriasis? Involving patients in curriculum development: modified Delphi technique
  • Monitoring in chronic disease: a rational approach
  • Role of specialists in common chronic diseases
  • Condition based payment: improving care of chronic illness

• Lancet 19 marzo
  • Social determinants of health inequalities

• N Engl J Med, 17 marzo
  • What Ails the FDA?
  • 2015 — The Future of Medical Libraries
  • Quiet in the Library
  • COX-2 Inhibitors — A Lesson in Unexpected Problems
  • COX-2 Inhibitors — Lessons in Drug Safety

• JAMA, 16 marzo
  • Potentially Inappropriate Medication Use Among Elderly Home Care Patients in Europe
  • Error Reporting and Disclosure Systems: Views From Hospital Leaders

• CMAJ, 15 marzo
  • Drug withdrawals from the Canadian market for safety reasons, 1963–2004

• BMJ, 12 marzo
  • Patients' safety
  • Validity of composite end points in clinical trials

• Lancet, 12 marzo
  • Offering participants results of a clinical trial: sharing results of a negative study

• JAMA, 9 marzo
  • Role of Computerized Physician Order Entry Systems in Facilitating Medication Errors
  • Effects of Computerized Clinical Decision Support Systems on Practitioner Performance and Patient Outcomes: A Systematic Review
  • The Unintended Consequences of Publicly Reporting Quality Information
  • Computer Technology and Clinical Work: Still Waiting for Godot

• Lancet 5 marzo
  • Evidence-based: US road and public-health side of the street
  • Evidence base for interventions in complex emergencies
  • 5 NICE years

• BMJ, 5 marzo
  • The nature of medical evidence and its inherent uncertainty for the clinical consultation: qualitative study
  • Commentary: Uncertainty, consultation, and the context of medical care
  • US and UK health care: a special relationship?: What can the UK and US health systems learn from each other?

• JAMA, 2 marzo
  • Impact of Participant and Physician Intervention Preferences on Randomized Trials: A Systematic Review

• CMAJ, 1 marzo
  • NNT for studies with long-term follow-up
  • Reason and rights in global drug control policy
  • Tips for learners of evidence-based medicine: 4. Assessing heterogeneity of primary studies in systematic reviews and whether to combine their results

• Arch Intern Med, 28 febbraio
  • Unintended Medication Discrepancies at the Time of Hospital Admission

• Lancet 26 febbraio
  • Safety concerns at the FDA

• BMJ, 26 febbraio
  • Ethics review of research and audit
  • Ethics, audit, and research: all shades of grey

• Bandolier 130

• JAMA, 23 febbraio
  • The Rational Clinical Examination.Does This Patient Have Influenza?

• BMJ, 19 febbraio
  • Learning in practice.Discussing randomised clinical trials of cancer therapy: evaluation of a Cancer Research UK training programme
  • Evidence based case report: Use of antibiotics in suspected haemolytic-uraemic syndrome

• Lancet, 19 febbraio
  • DAMOCLES Study Group. A proposed charter for clinical trial data monitoring committees: helping them to do their job well

• CMAJ, 15 febbraio
  • The availability of references and the sponsorship of original research cited in pharmaceutical advertisements
  • Enhanced weekend service: an affordable means to increased hospital procedure volume

• Ann Intern Med, 15 febbraio
  • Systematic Review: The Relationship between Clinical Experience and Quality of Health Care
  • "Practice Makes Perfect" ... Or Does It?
  • An Evidence-Based Guide to Writing Grant Proposals for Clinical Research

• N Engl J Med, 10 febbraio
  • Commercial Support and Continuing Medical Education

• MJA, 7 febbraio
  • Teaching on the run tips 7: effective use of questions

• JAMA, 2 febbraio
  • Missing Clinical Information During Primary Care Visits
  • Missing Clinical Information: The System Is Down
  • Improving Informed Consent and Enhancing Recruitment for Research by Understanding Economic Behavior
  • Research Compensation and the Monetarization of Medicine

• Ann Intern Med, 1 febbraio
  • Patients Exposed to Rofecoxib and Celecoxib Have Different Odds of Nonfatal Myocardial Infarction
  • Responding to the Rofecoxib Withdrawal Crisis: A New Model for Notifying Patients at Risk and Their Health Care Providers
  • Cardiovascular Risks of Cyclooxygenase-2 Inhibitors: Where We Stand Now
  • Using Information Technology To Transfer Knowledge: A Medical Institution Steps Up to the Plate

• Bandolier 129

• Lancet, 29 gennaio
  • Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study
  • COX-2 selective inhibitors--important lessons learned
  • Treating Individuals 5: Treatment with drugs to lower blood pressure and blood cholesterol based on an individual's absolute cardiovascular risk

• N Engl J Med, 27 gennaio
  • To Inform or Persuade? Direct-to-Consumer Advertising of Prescription Drugs
  • Medical Ethics: Consent or Obedience? Power and Authority in Medicine

• JAMA, 26 gennaio
  • Disease Management and the Organization of Physician Practice
  • Simple Principles of Clinical Trials Remain Powerful

• Arch Intern Med, 24 gennaio
  • Coxibs, Science, and the Public Trust

• Lancet, 23 gennaio
  • The whole truth and nothing but the truth? The research that Philip Morris did not want you to see
  • Treating Individuals 4: Can meta-analysis help target interventions at individuals most likely to benefit?

• BMJ 22 gennaio
  • Learning in practice. How doctors discuss major interventions with high risk patients: an observational study
  • The marketing of a disease: female sexual dysfunction

• N Engl J Med, 20 gennaio
  • Shattuck Lecture: Health Care in the 21st Century
  • Today's FDA

• JAMA, 19 gennaio
  • Arthritis Medicines and Cardiovascular Events—"House of Coxibs"

• CMAJ, 18 gennaio
  • Open access in medical publishing: trends and countertrends
  • Does the C in CME stand for "Continuing" or "Commercial"?
  • How should abridged scientific articles be presented in journals? A survey of readers and authors

• MJA, 17 gennaio 2005
  • A new integrated vision of how to prevent harmful drug use
  • Hypertension guidelines, meta-analyses and clinical trials: do we assume too much?
  • Trial on trials. Allocation concealment and blinding: when ignorance is bliss

• Lancet, 15 gennaio
  • Treating Individuals 3: From subgroups to individuals: general principles and the example of carotid endarterectomy
  • Greek kleroteria: the first randomisation technique?

• BMJ, 15 gennaio
  • Drug companies agree to make clinical trial results public
  • Clustering by health professional in individually randomised trials

• Bandolier 128

• Lancet 8 gennaio
  • European Clinical Research Infrastructures Network: promoting harmonisation and quality in European clinical research
  • Treating Individuals 2: Subgroup analysis in randomised controlled trials: importance, indications, and interpretation

• BMJ, 8 gennaio
  • Primary care trusts and primary care research
  • Comparing estimates of cost effectiveness submitted to the National Institute for Clinical Excellence (NICE) by different organisations: retrospective study
  • Optimal search strategies for retrieving systematic reviews from Medline: analytical survey
  • Need for expertise based randomised controlled trials
  • Letters (related EBM Theme Issue)

• JAMA, 5 gennaio 2005
  • Early release: Arthritis Medicines and Cardiovascular Events—"House of Coxibs"

• CMAJ, 4 gennaio
  • Vioxx: lessons for Health Canada and the FDA

• MJA, 3 gennaio 2005
  • From “silos” to seamless healthcare: bringing hospitals and GPs back together again

• Lancet 1 gennaio
  • Evidence-based practice and the individual
  • Treating Individuals 1 :External validity of randomised controlled trials: "To whom do the results of this trial apply?"

• BMJ 1 gennaio
  • The GMC: expediency before principle
  • Direct to consumer advertising
  • ABC of preterm birth: Evidence based care
  • Switching prescription drugs to over the counter

• N Engl J Med, 30 dicembre
  • Potential Pitfalls of Disease-Specific Guidelines for Patients with Multiple Conditions